Mark Kowalski
2017 - ProNAi Therapeutics
In 2017, Mark Kowalski earned a total compensation of $863.8K as Chief Medical Officer at ProNAi Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $132,062 |
|---|---|
| Option Awards | $351,707 |
| Salary | $377,320 |
| Other | $2,700 |
| Total | $863,789 |
Kowalski received $377.3K in salary, accounting for 44% of the total pay in 2017.
Kowalski also received $132.1K in non-equity incentive plan, $351.7K in option awards and $2.7K in other compensation.
Rankings
In 2017, Mark Kowalski's compensation ranked 9,684th out of 14,666 executives tracked by ExecPay. In other words, Kowalski earned more than 34.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,684 out of 14,666 | 34th |
Division Manufacturing | 3,735 out of 5,768 | 35th |
Major group Chemicals And Allied Products | 1,295 out of 2,074 | 38th |
Industry group Drugs | 1,044 out of 1,730 | 40th |
Industry Pharmaceutical Preparations | 822 out of 1,329 | 38th |
Source: SEC filing on April 24, 2018.
Kowalski's colleagues
We found two more compensation records of executives who worked with Mark Kowalski at ProNAi Therapeutics in 2017.